Delivery Order SPE2DB20D2014-SPE2DB25FD00V
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,491,490 units of Mitomycin 40 mg vials. The order, valued at $2,295.00, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, is a prime contractor providing pharmaceutical products and medical supplies to U.S. government...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,807.37 to AmerisourceBergen Drug Corp on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The delivery order will be fulfilled...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $27,081.44 for Mylotarg 4.5 mg vials under a Defense Logistics Agency contract with the Medical Supply Chain. The award, made on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed price, competitively awarded delivery against an existing contract vehicle. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order does not...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,205.76 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This delivery order, valued at $14,528.80 and awarded September 3, 2025, represents a competitive procurement by the Defense Logistics Agency (DLA) for MENQUADFI vials (0.5mL) from AmerisourceBergen Drug Corp, the primary pharmaceutical distributor for federal military and healthcare systems. The award is non-set-aside and utilizes firm fixed-price pricing, with completion scheduled for September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,038.61 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,555.77 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at the...
- This delivery order, valued at $2,364.00, was awarded to AmerisourceBergen Drug Corp on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order functions as a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...